Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8(+) T Cell Responses

Cancer vaccination aims at inducing an adaptive immune response against tumor-derived antigens. In this study, we utilize recombinant human adenovirus serotype 5 (rAd5) and recombinant lymphocytic choriomeningitis virus (rLCMV)-based vectors expressing the melanocyte differentiation antigen gp100. I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Oncolytics
Main Authors: Ring, Sandra S., Królik, Michał, Hartmann, Fabienne, Schmidt, Erika, Ali, Omar Hasan, Ludewig, Burkhard, Kochanek, Stefan, Flatz, Lukas
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7658660/
https://ncbi.nlm.nih.gov/pubmed/33209978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.10.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados